𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Managing the Refractory Idiopathic Overactive Bladder with OnabotulinumtoxinA: Phase 2 Trial

✍ Scribed by Timothy B. Boone

Book ID
107534594
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
54 KB
Volume
6
Category
Article
ISSN
1931-7212

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Weekly treatment with bortezomib for pat
Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma : A phase 2 trial of the Minnie Pearl Cancer Research Network
✍ John D. Hainsworth; David R. Spigel; John Barton; Cindy Farley; Marshall Schreed πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The purpose of the current study was to evaluate the efficacy and toxicity of weekly bortezomib in the treatment of patients with recurrent/refractory multiple myeloma. ## METHODS. A total of 40 patients with multiple myeloma who had received either 1 or 2 previous tre

A Phase I/IB trial of murine monoclonal
A Phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma : A report of the Children's Cancer Group
✍ Jami D. Frost; Jacquelyn A. Hank; Gregory H. Reaman; Sharon Frierdich; Robert C. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 2 views

Phase I/IB study of the Children's Cancer Group (CCG) and were monitored for toxicities and response

Efficacy and safety of the combination o
Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden : A multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des LeucΓ©mies et Autres Maladies du Sang (GOELAMS)
✍ Franck Morschhauser; Nicolas Mounier; Catherine Sebban; Pauline Brice; Phillippe πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 219 KB